Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
Christopher Still, DO, director of Geisinger Obesity Institute, shares common questions he receives from patients about weight loss, as well as the impact of fad diets, unregulated supplements, and online...
Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.
Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.
Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.
Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.
A recent study led by Kerry Flannagan, PhD, examined how opioid use may result in pregnancy loss and lower changes of conception. Dr Flannagan answered our questions about her team’s study.
